Register information Patent

DE file number : 60 2010 062 875.2 (Status: pending/in force, Query started: April 26, 2025)

Please note: This English version is a non-binding translation of the German register excerpt. Only the German version of the register excerpt is legally binding.

Master data
INIDCriterionFieldContent
Type of IP rightSARTPatent
StatusSTPending/in force
21DE file number DAKZ60 2010 062 875.2
96EP file numberEAKZ17 18 9247.4
97EP publication numberEPN3305813
54Designation/titleTIFÜR CLAUDIN 6 (CLDN6) SPEZIFISCHE ANTIKÖRPER
51IPC main classICM
(ICMV)		 C07K 16/28 (2006.01)
51IPC secondary class(es)ICS
(ICSV)		 C07K 14/705 (2006.01), A61P 35/00 (2006.01), A61K 39/395 (2006.01), C07K 16/30 (2006.01), A61K 39/00 (2006.01)
22DE application dateDATNov 11, 2010
96EP application dateEATNov 11, 2010
43Date of first publicationOTApr 11, 2018
Date of publication of grantPETJan 15, 2020
71/73Applicant/ownerINHAstellas Pharma Inc., Tokyo, JP; TRON - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz gemeinnützige GmbH, 55131 Mainz, DE
72InventorINSahin, Ugur, 55116 Mainz, DE; Türeci, Özlem, 55116 Mainz, DE; Koslowski, Michael, 85764 Oberschleissheim, DE; WALTER, Korden, 65203 Wiesbaden, DE; WÖLL, Stefan, 55299 Nackenheim, DE; KREUZBERG, Maria, 55131 Mainz, DE; HUBNER, Bernd, 80933 München, DE; ERDELJAN, Michael, 55131 Mainz, DE
74RepresentativeVTRZwicker Schnappauf & Partner Patentanwälte PartG mbB, 80686 München, DE
Address for service Zwicker Schnappauf & Partner Patentanwälte PartG mbB, 80686 München, DE
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
361618 P
Jul 6, 2010
33
31
32
Foreign priorityPRC
PRNA
PRDA
EP
09014136
Nov 11, 2009
33
31
32
Foreign priorityPRC
PRNA
PRDA
EP
10006956
Jul 6, 2010
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
260202 P
Nov 11, 2009
Due dateFT
FG		Nov 30, 2025
Annual fee for the 16th year Patent fees
Patent division in charge 44
97EP language of publicationELANGEN - Englisch
84Designated EP contracting statesEDSAL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Published EP/WO documentsEPWOPNOriginal document: EP000003305813A1
Searchable text: EP000003305813A1
Original document: EP000003305813B1
Searchable text: EP000003305813B1
43Date of first publicationEVTApr 11, 2018
Date of the first transfer into DPMAregisterEREGTApr 11, 2018
Date of the (most recent) update in DPMAregisterREGTDec 4, 2024
(Show all update days)(Hide all update days)
  • Dec 4, 2024
    • Due date: changed
  • Aug 22, 2024
    • St.36: changed (technical change)
  • Dec 6, 2023; Aug 31, 2023; Jul 25, 2023; Dec 2, 2022; Dec 6, 2021; Jan 8, 2021; Dec 5, 2020; Dec 3, 2020; Jan 18, 2020; Jan 17, 2020; Jan 8, 2020; Jan 2, 2020; Oct 4, 2018
    • Historical data not available for this/these date(s)
  • Apr 11, 2018
    • Date of the first transfer into DPMAregister
Procedural data
No.Kind of procedureLegal statusDate of legal/procedural statusPublication dateAlle Details anzeigen
1 Procedure relating to EP application EPO 1st publication Apr 11, 2018  Details anzeigen
2 Publications Publication of a mention regarding EP 1st publication by DPMA May 24, 2018 May 24, 2018 Details anzeigen
3 Procedure relating to EP application EPO publication of mention regarding patent grant (beginning of opposition period) Jan 15, 2020  Details anzeigen
4 Publications Publication by DPMA of mention regarding EP patent grant Feb 13, 2020 Feb 13, 2020 Details anzeigen
5 Procedure relating to EP application No opposition to patent grant filed, or opposition proceedings at EPO completed without decision Oct 16, 2020 Jan 7, 2021 Details anzeigen
6 New applicant/owner details New applicant/owner details Jul 24, 2023 Aug 31, 2023 Details anzeigen
View procedures Procedure relating to EP application (No.: 1)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO 1st publication
Date of legal/procedural statusVSTTApr 11, 2018
View procedures Publications (No.: 2)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication of a mention regarding EP 1st publication by DPMA
Date of legal/procedural statusVSTTMay 24, 2018
Issue numberHN21
YearPJ2018
Publication dateVTMay 24, 2018
Type of publicationPARTBibliographic data
View procedures Procedure relating to EP application (No.: 3)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO publication of mention regarding patent grant (beginning of opposition period)
Date of legal/procedural statusVSTTJan 15, 2020
View procedures Publications (No.: 4)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication by DPMA of mention regarding EP patent grant
Date of legal/procedural statusVSTTFeb 13, 2020
Issue numberHN7
YearPJ2020
Publication dateVTFeb 13, 2020
Type of publicationPARTBibliographic data
PartHTPart 5
View procedures Procedure relating to EP application (No.: 5)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTNo opposition to patent grant filed, or opposition proceedings at EPO completed without decision
Date of legal/procedural statusVSTTOct 16, 2020
Issue numberHN1
YearPJ2021
Publication dateVTJan 7, 2021
Type of publicationPARTBibliographic data
PartHTPart 3
Date of update of the procedureREGTJan 8, 2021
View procedures New applicant/owner details (No.: 6)
INIDCriterionFieldContent Close details
Type of procedureVARTNew applicant/owner details
Legal/procedural statusVSTNew applicant/owner details
Date of legal/procedural statusVSTTJul 24, 2023
Issue numberHN35
YearPJ2023
Publication dateVTAug 31, 2023
Type of publicationPARTBibliographic data
PartHTPart 3
71/73Applicant/ownerINHAstellas Pharma Inc., Tokyo, JP; TRON - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz gemeinnützige GmbH, 55131 Mainz, DE
71/73Previous applicant/ownerINHFGanymed Pharmaceuticals GmbH, 55131 Mainz, DE, Johannes Gutenberg-Universität Mainz, 55128 Mainz, DE
Date of update of the procedureREGTAug 31, 2023